Their solution, VetEvince, went beyond simple automation or AI chat assistants. It promised to deliver insights anchored in ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: New Data: “Admission-First” AI ...

While Silicon Valley pours billions into longevity tech and concierge medicine for the ultra-wealthy, OMNY Health is building something far more radical: a data infrastructure that can actually ...

Rocatinlimab, targeting the OX40 pathway, shows significant efficacy in moderate to severe atopic dermatitis, marking a new therapeutic class in disease management. Long-term melanoma data reveal ...

Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

Application developers and solution partners often need to process healthcare data outside of the electronic medical record (EMR) system. EMRs are primarily designed to directly support individual ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. With more than a third of hospitals experiencing negative operating margins, healthcare ...

Payer-provider clinical data exchange plays a critical role in payer operations, helping streamline workflows and improve patient care. Traditionally, this exchange ...

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases, announced today the company will present three ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

Jasper Therapeutics, Inc. announced that it is presenting updated clinical data from its Phase 1b/2a BEACON study on briquilimab, an antibody therapy targeting c-Kit to treat mast cell-driven diseases ...

This article is part of our series on clinical data considerations. Read How to Approach Fundraising and Investor Relations. When it comes to disclosing clinical trial data in the biotechnology arena, ...